Anne Minto
Non-Executive Director @ Shire
London, United Kingdom
Anne Minto is a startup investor at Shire in London. Anne was appointed to the Board on June 16, 2010 and is Chairman of the Remuneration Committee and a member of the Nomination Committee.Anne brings to the Board her extensive legal, commercial and remuneration experience. She is a Non-Executive Director of Tate & Lyle PLC and ExlService Holdings, Inc. and is a former Director of NorthumbrianWater plc and SITA UK.Anne held the position of Group Director, Human Resources at Centrica plc from October 2002 to 30 June 2011 and was a member of the Centrica Executive Committee. Her extensive business career includes senior management roles at Shell UK, the position of Deputy Director-General of the Engineering Employers’ Federation and the position of Group Director Human Resources at Smiths Group plc. Following her law degree at Aberdeen University and a postgraduate diploma in Human Resources she qualified as a lawyer.Anne is a Fellow of the Chartered Institute of Personnel & Development, the Royal Society of Arts and the London City and Guilds and a Member of Law Society of Scotland.She is a trustee of the University of Aberdeen Development Trust and is Patron of the University of Aberdeen Alumni Fund.
Last updated:
For AI agents: llms.txt
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.At Shire, the company ground everything they do intheir purpose of enabling people with life altering conditions to lead better lives. The company's patient and customer focused culture encourages employees to embrace innovation and challenge the status quo through respectful and inclusive engagement with colleagues. Honesty and transparency are inherent in all that we do as we work with a high sense of urgency to become a leading global biotech delivering innovative therapies to patients with rare diseases and other specialty conditions. We foster an environment where leaders are positive, accountable, results driven and great people managers. Our employees own their development in partnership with their manager, understand and leverage their strengths, bring their whole selves to work, and like the leaders they are expected to eventually become, share the essential traits of positive, accountable and results driven. Our non-hierarchical structure and clear reporting lines enable quick decision making, nimble execution and the opportunity for employees to enjoy the work and grow to their fullest potential. The company is committed to recruit, develop and retain top talent who take a responsible and ethical approach to all that we do and who want to make a difference in the lives of patients across the globe.
Shire Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anne Minto
Non-Executive Director
|
|||
Anthony Trupiano
Director Combination Product Device Development
|
|||
|
Bernhard Schimmele
Head Global Stability
|
|||
|
Christa Tauer
VP Process Development Biologics
|
|||
Dhairya Mehta
Associate Director of Device and Combination Products
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
